Kyntra Bio appoints Andrew E. Singer to board, names him audit committee member

KYNB•2026-10-01

Andrew E. Singer joined Kyntra Bio’s board as an independent director and audit committee member effective Oct. 1, 2026. Maykin Ho stepped down effective Sept. 30, 2026.

Kyntra Bio appoints Andrew E. Singer to board, names him audit committee member

1. Board changes

Related News

Arbutus Biopharma buys back 46 million shares for $230 million in Dutch auction

Sanofi’s Regeneron fix requires extra shot of M&A

McCormick beats quarterly results estimates on higher product prices

Westlake Corp: Truist Securities cuts target price to $90 from $104

JonesTrading raises Spyre Therapeutics target price to $130 from $121